Wells Fargo & Company began coverage on shares of MorphoSys (NASDAQ:MOR – Get Rating) in a research note released on Friday morning, The Fly reports. The firm issued an overweight rating and a $17.00 target price on the stock. A number of other equities analysts have also commented on the company. UBS Group assumed coverage […]